- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/36 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetylamino 2-deoxy-D-glucose, e.g. lysozyme
Patent holdings for IPC class C12N 9/36
Total number of patents in this class: 426
10-year publication summary
|
29
|
26
|
39
|
40
|
41
|
36
|
25
|
30
|
22
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novozymes A/S | 3350 |
48 |
| Lysando AG | 41 |
28 |
| Micreos Human Health B.V. | 34 |
14 |
| Comera Life Sciences, Inc. | 26 |
14 |
| The Rockefeller University | 584 |
12 |
| DSM IP Assets B.V. | 5456 |
11 |
| Quiapeg Pharmaceuticals AB | 41 |
11 |
| Bactoclear Holdings Pte. Ltd. | 19 |
9 |
| Danisco US Inc. | 1124 |
7 |
| Katholieke Universiteit Leuven K.u. Leuven R & D | 208 |
7 |
| Hypharm GmbH | 11 |
6 |
| Asahi Kasei Kabushiki Kaisha | 2745 |
5 |
| Sasinapas Co., Ltd. | 11 |
5 |
| BioNTech SE | 759 |
5 |
| ContraFect Corporation | 64 |
5 |
| Aurobac Therapeutics SAS | 11 |
5 |
| The Regents of the University of California | 20410 |
4 |
| Massachusetts Institute of Technology | 10183 |
4 |
| The United States of America, as represented by the Secretary of Agriculture | 1135 |
4 |
| LyseNTech Co., Ltd. | 5 |
4 |
| Other owners | 218 |